📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Maha Rashtra Apex Corp Assigns ISIN INE843B20013 for Rights Entitlements
Maha Rashtra Apex Corporation Limited has finalized the International Securities Identification Number (ISIN) for its upcoming Rights Issue. The ISIN INE843B20013 has been assigned for the credit of Rights Entitlements (RE) into the demat accounts of eligible shareholders. The company has coordinated with NSDL and CDSL to ensure the REs are credited before the issue opening date. This is a procedural step following the company's decision to raise capital through a rights offering.
Key Highlights
ISIN for Rights Entitlements identified as INE843B20013
Arrangements completed with NSDL and CDSL for dematerialized credit
Rights Entitlements to be credited to eligible shareholders prior to the issue opening date
Compliance with SEBI Rights Issue Circulars updated as of March 9, 2026
💼 Action for Investors
Eligible shareholders should monitor their demat accounts for the credit of Rights Entitlements and review the Rights Issue price and timeline once announced to decide on participation.
Maha Rashtra Apex Corp Sets March 20, 2026, as Record Date for Rights Issue
Maha Rashtra Apex Corporation Limited has announced March 20, 2026, as the record date for its upcoming Rights Issue of equity shares. This decision was finalized during the Board Meeting held on March 11, 2026. The record date will determine which shareholders are eligible to receive Rights Entitlements (REs) to participate in the capital raise. This move follows the company's compliance with Regulation 42 of SEBI Listing Regulations.
Key Highlights
Record date for Rights Issue eligibility is fixed for March 20, 2026
Board of Directors approved the timeline in a meeting held on March 11, 2026
The issue aims to provide Rights Entitlements to existing equity shareholders
The company is listed on both BSE (523384) and NSE (MAHAPEXLTD)
💼 Action for Investors
Investors interested in participating in the Rights Issue must ensure they hold the company's shares before the record date. Closely monitor upcoming disclosures regarding the rights price and entitlement ratio to assess the investment's value.
Maha Rashtra Apex Corp to Raise ₹14.09 Cr via 1:1 Rights Issue at ₹10/Share
Maha Rashtra Apex Corporation has approved a Rights Issue of up to 1.41 crore equity shares at a price of ₹10 per share, which is at par with the face value. The issue follows a 1:1 ratio, allowing existing shareholders to subscribe to one new share for every share held as of the record date, March 20, 2026. The total fundraise is expected to be approximately ₹14.09 crore, effectively doubling the company's outstanding equity base if fully subscribed. The subscription window is scheduled from April 2 to April 30, 2026.
Key Highlights
Rights Issue ratio fixed at 1:1 (one new share for every one share held)
Issue price set at ₹10 per share, aggregating to a total size of ₹1,409.19 Lakhs
Record date for eligibility is March 20, 2026, with the issue opening on April 2, 2026
Post-issue equity capital will double to 2,81,83,792 shares assuming full subscription
Last date for market renunciation of rights entitlements is April 29, 2026
💼 Action for Investors
Investors should evaluate the current market price against the ₹10 issue price; if the market price is higher, they should either subscribe or sell their rights entitlements before April 29 to avoid dilution.
Maha Rashtra Apex to Finalize Rights Issue Terms on March 11; Trading Window Closed
Maha Rashtra Apex Corporation Limited has announced a trading window closure starting March 7, 2026, ahead of a crucial board meeting. The Board of Directors is scheduled to meet on March 11, 2026, to finalize the terms of a proposed Rights Issue. Key decisions will include the pricing terms, the Rights entitlement ratio, and the official schedule of the issue. The trading window will remain closed for designated persons until 48 hours after the board's decisions are disclosed to the exchanges.
Key Highlights
Trading window for designated persons closed from March 7, 2026.
Board meeting scheduled for March 11, 2026, to approve Rights Issue details.
Agenda includes determining the pricing terms and Rights entitlement ratio.
Approval and adoption of the Letter of Offer expected during the meeting.
Trading window to reopen 48 hours after the announcement of board outcomes.
💼 Action for Investors
Investors should closely monitor the March 11 announcement for the Rights Issue price and entitlement ratio to determine the potential for dilution. Assess the company's stated purpose for the fundraise before deciding to exercise rights.
Maha Rashtra Apex Receives Stock Exchange Approval for Rights Issue
Maha Rashtra Apex Corporation Limited has successfully obtained in-principle approval from both the National Stock Exchange (NSE) and BSE Limited for its proposed Rights Issue of equity shares. The BSE approval was granted on March 4, 2026, while the NSE approval followed on March 5, 2026. This development follows the company's initial application submitted to the exchanges on December 20, 2025. The approval marks a critical regulatory milestone in the company's efforts to raise capital through existing shareholders.
Key Highlights
Received in-principle approval from NSE on March 5, 2026, for the Rights Issue.
Received in-principle approval from BSE on March 4, 2026, for the equity issuance.
Follows the initial application process initiated by the company on December 20, 2025.
The fundraising is being conducted under Regulation 30 of SEBI Listing Regulations.
💼 Action for Investors
Investors should watch for the announcement of the Rights Issue price, ratio, and record date to evaluate the potential dilution and the attractiveness of the offer.
Apex Frozen Foods Q3 PAT Jumps to ₹10 Cr; Revenue Up 15% YoY to ₹264 Cr
Apex Frozen Foods reported a significant turnaround in Q3FY26, with PAT rising to ₹10 crore from ₹0.5 crore in the previous year, driven by lower raw material costs and improved realizations. Revenue grew 15% YoY to ₹264 crore, supported by a 22% growth in EU sales which helped offset a 12% decline in US volumes. Management highlighted a major regulatory tailwind as US shrimp export tariffs were reduced from 50% to 25% in February 2026. The company has successfully diversified its revenue, with non-US markets now contributing 51% of total sales compared to 37% a year ago.
Key Highlights
Net revenue for Q3FY26 grew 15% YoY to ₹264 crore, while 9M FY26 revenue reached ₹761 crore.
EBITDA surged 147% YoY to ₹17 crore, with margins expanding by 344 bps to 6.5% due to lower input costs.
US import tariffs on Indian shrimp reduced from 50% to 25% effective February 7, 2026.
Raw material prices dropped to ₹327 per kg in Q3FY26 from ₹374 per kg in the same quarter last year.
Management guided for a revenue target of ₹1,200+ crore over the next two years driven by capacity utilization.
💼 Action for Investors
Investors should view the tariff reduction and the shift toward the EU market as structural positives for long-term volume growth. Monitor the upcoming Q4 results for the impact of rising farmgate prices on margins.
Apex Frozen Foods Q3FY26 PAT Surges to Rs 101 Mn; EBITDA Margins Expand to 6.5%
Apex Frozen Foods reported a robust Q3FY26 performance with revenue growing 15% YoY to Rs 2,643 Mn, driven by higher realizations and strong growth in the European market. Profitability saw a massive turnaround as PAT jumped to Rs 101 Mn from a low base of Rs 5 Mn last year, supported by lower raw material costs and improved operational efficiencies. While US sales were previously impacted by high tariffs, the recent reduction in US shrimp import duties from 50% to 25% effective February 2026 is expected to boost future volumes. The company maintains a very healthy balance sheet with a net debt-to-equity ratio of just 0.05x.
Key Highlights
Net Revenue for Q3FY26 grew 15% YoY to Rs 2,643 Mn, while 9MFY26 revenue rose 23% to Rs 7,608 Mn.
EBITDA for the quarter increased 147% YoY to Rs 173 Mn, with margins expanding by 344 bps to 6.5%.
PAT witnessed a massive recovery, surging 1887% YoY to Rs 101 Mn in Q3FY26 from Rs 5 Mn in the year-ago period.
EU sales volumes grew 22% YoY in Q3FY26, helping diversify the sales mix as US sales faced tariff headwinds.
Total borrowings have been consistently reduced, with Net Debt to Equity improving to 0.05x as of September 2025.
💼 Action for Investors
Investors should view the sharp margin recovery and debt reduction positively, while monitoring the impact of the halved US tariffs on volume growth in upcoming quarters. The shift towards the EU market and value-added products provides a good hedge against US-specific regulatory risks.
Maha Rashtra Apex Reports Q3 Net Profit of ₹1.92 Cr; Appoints Rights Issue Monitor
Maha Rashtra Apex Corporation Limited reported a significant turnaround in Q3 FY26, posting a net profit of ₹192.35 lakhs compared to a loss of ₹19.63 lakhs in the same quarter last year. Total income surged to ₹232.57 lakhs, driven by a sharp increase in revenue from operations. However, auditors issued a qualified opinion, noting that the company failed to provide for ₹12.01 lakhs in interest costs this quarter, which overstates the reported profit. The board also appointed Brickwork Ratings as the monitoring agency for its upcoming Rights Issue.
Key Highlights
Net Profit turned positive at ₹192.35 lakhs for Q3 FY26 against a loss of ₹19.63 lakhs in Q3 FY25.
Total Income grew substantially to ₹232.57 lakhs from ₹25.16 lakhs in the year-ago period.
Auditors flagged a cumulative unprovided interest liability of ₹369.71 lakhs since October 2019, overstating current profits.
The company has deposited ₹1,395.75 lakhs with the Karnataka High Court regarding outstanding public deposits and bonds.
Brickwork Ratings India Private Limited appointed as the monitoring agency for the proposed Rights Issue.
💼 Action for Investors
Investors should exercise caution as the reported profits are overstated due to unprovided interest liabilities and the company's NBFC license remains cancelled by the RBI. Monitor the progress of the Rights Issue and the resolution of legal disputes regarding public deposits.
Apex Frozen Foods Q3 FY26 PAT at ₹10.09 Cr, YoY Turnaround from Loss
Apex Frozen Foods reported a significant YoY turnaround in Q3 FY26, posting a net profit of ₹1,009 Lakhs compared to a loss of ₹22.24 Lakhs in the same period last year. Revenue from operations grew by 14.5% YoY to ₹26,428.71 Lakhs, reflecting improved demand in the shrimp processing segment. For the nine-month period ended December 2025, the company's PAT surged to ₹3,106.09 Lakhs from ₹191.20 Lakhs in the previous year, indicating a strong recovery in profitability. However, on a sequential basis, PAT declined from ₹1,187.23 Lakhs in Q2 FY26 due to higher operational expenses.
Key Highlights
Revenue from operations increased 14.5% YoY to ₹26,428.71 Lakhs in Q3 FY26.
Net Profit turned positive at ₹1,009 Lakhs vs a loss of ₹22.24 Lakhs in Q3 FY25.
9M FY26 PAT grew exponentially to ₹3,106.09 Lakhs compared to ₹191.20 Lakhs in 9M FY25.
Export benefits contributed ₹1,244.05 Lakhs to the revenue during the quarter.
Earnings Per Share (EPS) improved to ₹3.23 in Q3 FY26 from negative ₹0.07 in Q3 FY25.
💼 Action for Investors
Investors should view the strong YoY recovery and 9M performance as a sign of operational stabilization, though the sequential dip in profit suggests a need to monitor rising other expenses. The stock remains a key play on global shrimp demand and the continuation of government export incentives.
Maha Rashtra Apex Corp Files Draft Letter of Offer for Proposed Rights Issue
Maha Rashtra Apex Corporation Limited has officially filed the Draft Letter of Offer (DLOF) with BSE and NSE for its proposed Rights Issue. This follows the Board's approval for fundraising granted on December 18, 2025. The company is currently seeking in-principle listing approval and regulatory comments on the draft document. While the specific issue size and pricing details are yet to be finalized in the public domain, this filing marks a formal step in the capital-raising process.
Key Highlights
Filed Draft Letter of Offer (DLOF) dated December 19, 2025, with BSE and NSE.
Seeking in-principle listing approval for the proposed Rights Issue of equity shares.
The filing follows the Board of Directors' fundraising approval from December 18, 2025.
The Right Issue Committee has formally approved the DLOF for submission to regulators.
💼 Action for Investors
Investors should monitor upcoming announcements for the rights entitlement ratio, issue price, and record date to assess potential dilution. Review the final Letter of Offer to understand how the company intends to utilize the raised capital.
Maha Rashtra Apex Board Approves ₹15 Crore Rights Issue at ₹10 Per Share
Maha Rashtra Apex Corporation Limited has approved a fundraise of up to ₹15 crore through the issuance of equity shares on a rights basis. The board has fixed the issue price at ₹10 per share, which is the face value of the stock. The rights entitlement ratio is set at 15,000,000 equity shares for every 14,090,896 shares held by eligible shareholders. A Rights Issue Committee has been constituted to finalize the record date and other specific terms of the issue.
Key Highlights
Fundraise of up to ₹15 crore through equity shares on a rights basis
Issue price fixed at ₹10 per share, matching the face value
Rights ratio of 15,000,000 shares for every 14,090,896 shares held
Constitution of a Rights Issue Committee to manage the process and finalize the record date
Board meeting concluded on December 18, 2025, with immediate approval
💼 Action for Investors
Investors should monitor for the announcement of the record date to determine eligibility for the rights. Compare the ₹10 issue price with the current market price to evaluate the potential for arbitrage or dilution impact.
Maha Rashtra Apex Corp to Raise Rs 15 Crore via Rights Issue at Rs 10 Per Share
Maha Rashtra Apex Corporation Limited has approved a rights issue to raise up to Rs 15 crore through the issuance of new equity shares. The Board has set the issue price at Rs 10 per share, which matches the face value. The entitlement ratio is approximately 1.06 shares for every 1 share held (15,000,000:14,091,896). A dedicated Rights Issue Committee has been formed to finalize the record date and other specific terms of the offering.
Key Highlights
Total fundraise amount capped at Rs 15,00,00,000 (Rs 15 Crore).
Issue price fixed at Rs 10 per equity share.
Entitlement ratio set at 15,000,000 equity shares for every 14,091,896 shares held.
Board has authorized the constitution of a Rights Issue Committee to manage the process.
Record date and further terms to be notified subsequently by the committee.
💼 Action for Investors
Investors should monitor the current market price relative to the Rs 10 issue price to assess the discount and decide on participation. Existing shareholders should watch for the record date announcement to ensure eligibility for the rights entitlement.